Health Robotics, a global supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, is reportedly planning to expand and diversify its global channel strategies with joint-ventures and direct operations.

 

As part of this new strategy, the company mentioned that it is entering direct operations in Germany via a contract with Charite-Universitatsmedizin, Berlin. Additionally, the company is planning to establish joint ventures in North America and South East Asia and also expand its indirect channel partner line-up in Taiwan and Oceania.

 

"This key milestone to diversify and expand beyond our traditional indirect channels demonstrates the company's maturity and its financial stability in this global economic crisis, already proven with the recent release of 2008 Financial Results,” said Werner Rainer, chief executive officer of Health Robotics.

 

Health Robotics has been offering healthcare facilities in four continents with robotics technology and software automation solutions. The company claims that its CytoCare, i.v.STATION, and TPNstation contribute to ease global hospitals' growing pressures to improve patient safety through the production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain costs.

 

Rainer mentioned that though Health Robotics is committed to its indirect channel partners, it has become necessary to take this step in order to protect the customers' investments in Health Robotics' technology and insulate them from the negative effects.

 

“Without this swift intervention, some of these factors could potentially have had a serious negative impact of the on-time delivery of our products to customers, something we are not willing to tolerate. At Health Robotics, our customers' best interests shall always take precedence over other marketing or sales channels factors or considerations", said Rainer.